Penserra Capital Management LLC Seelos Therapeutics, Inc. Transaction History

Penserra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.51 - $0.93 $15,443 - $28,162	-30,282 Reduced 8.11%	343,215 $233,000
Q1 2022 May 13, 2022	BUY	$0.84 - $1.71 $44,880 - $91,363	53,429 Added 16.69%	373,497 $235,000
Q4 2021 Feb 15, 2022	BUY	$1.59 - $2.38 $96,843 - $144,961	60,908 Added 23.5%	320,068 $521,000
Q3 2021 Nov 15, 2021	BUY	$1.69 - $2.89 $263,104 - $449,923	155,683 Added 150.45%	259,160 $624,000
Q2 2021 Aug 12, 2021	BUY	$2.64 - $6.32 $273,179 - $653,974	103,477 New	103,477 $273,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $32M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.